CACNB4 and nervous system disorder: Together, by a combination of in silico tools, animal model, clinical, and genetic data, we suggest that the homozygous p.(Leu126Pro) amino acid substitution in CACNB4 is the likely variant to underlie the patients’ neurological disease, although there is still a degree of uncertainty.